These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11361484)

  • 21. Changing requirements for evaluation of pharmacologic agents.
    Chesney RW; Christensen ML
    Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pediatric clinical trial experience: government, child, parent and physician's perspective.
    Salazar JC
    Pediatr Infect Dis J; 2003 Dec; 22(12):1124-7. PubMed ID: 14688585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The United States Food and Drug Administration guidelines on ambulatory blood pressure monitoring.
    Lipicky R
    J Hypertens Suppl; 1991 Dec; 9(8):S59. PubMed ID: 1795204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The investigative process for new drugs.
    Nicklas RA
    Ann Allergy; 1989 Dec; 63(6 Pt 2):598-600. PubMed ID: 2688499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obtaining pediatric indications for new anti-epileptic drugs: how and when.
    Garofalo E
    Epilepsy Res; 2006 Jan; 68(1):38-42. PubMed ID: 16377135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pemetrexed in malignant pleural mesothelioma.
    Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
    Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom-reduction trials at FDA clinical trials workshop. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Sep; (no 231):7. PubMed ID: 11362873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Innovative approaches in drug development.
    Chang M; Kenley S; Bull J; Chiu YY; Wang W; Wakeford C; McCarthy K
    J Biopharm Stat; 2007; 17(5):775-89. PubMed ID: 17885865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA community meeting May 16: clinical trials and viral load. Food and Drug Administration.
    AIDS Treat News; 1997 May; (No 270):3. PubMed ID: 11364324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic vaccine trails in Thailand.
    Churdboonchart V
    J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
    Gibson JE; Taylor DA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Guidelines for new antiepileptic drug evaluation.
    Hixson JD; French JA
    Rev Neurol Dis; 2004; 1 Suppl 1():S18-26. PubMed ID: 16400291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing participation of women in early phase clinical trials approved by the FDA.
    Pinnow E; Sharma P; Parekh A; Gevorkian N; Uhl K
    Womens Health Issues; 2009; 19(2):89-93. PubMed ID: 19272558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug trials in children: ethical, legal, and practical issues.
    Kauffman RE
    J Clin Pharmacol; 1994 Apr; 34(4):296-9. PubMed ID: 8006195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statistical considerations in clinical field evaluation of drugs.
    Powers JD; Powers TE
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1151-2. PubMed ID: 7216891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring of clinical investigations; availability of guideline--FDA. Notice.
    Fed Regist; 1988 Feb; 53(31):4723-4. PubMed ID: 10285639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug testing in children.
    Greene J
    FDA Consum; 1978 Jun; 12(5):11-3. PubMed ID: 10308116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leveraging prior quantitative knowledge in guiding pediatric drug development: a case study.
    Jadhav PR; Zhang J; Gobburu JV
    Pharm Stat; 2009; 8(3):216-24. PubMed ID: 19610013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of one-sided tests in drug trials: an FDA advisory committee member's perspective.
    Fisher LD
    J Biopharm Stat; 1991; 1(1):151-6. PubMed ID: 1844686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.